Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
Public ClinicalTrials.gov record NCT00036101. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn if aripiprazole is effective for the treatment of patients with acute symptoms of Bipolar disorder.
Study identification
- NCT ID
- NCT00036101
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2002
- Primary completion
- Dec 31, 2002
- Completion
- Dec 31, 2002
- Last update posted
- Nov 10, 2013
2002 – 2003
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Tuscaloosa | Alabama | — | — |
| Local Institution | Little Rock | Arizona | — | — |
| Local Institution | Beachwood | California | — | — |
| Local Institution | Chula Vista | California | — | — |
| Local Institution | Riverside | California | — | — |
| Local Institution | San Clemente | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | Stanford | California | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | North Miami | Florida | — | — |
| Local Institution | Winter Park | Florida | — | — |
| Local Institution | Honolulu | Hawaii | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Indianapolis | Indiana | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | Belmont | Massachusetts | — | — |
| Local Institution | Newton Center | Massachusetts | — | — |
| Local Institution | New Baltimore | Michigan | — | — |
| Local Institution | Lawrence | New York | — | — |
| Local Institution | Butner | North Carolina | — | — |
| Local Institution | Cincinnati | Ohio | — | — |
| Local Institution | Medina | Ohio | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Houston | Texas | — | — |
| Local Institution | Falls Church | Virginia | — | — |
| Local Institution | Bellevue | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00036101, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 10, 2013 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00036101 live on ClinicalTrials.gov.